Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.31 | -23.37 |
PEG Ratio (TTM) | -0.01 | -7.10 |
P/S Ratio (TTM) | 1.32 | 44.34 |
P/B Ratio (TTM) | 0.69 | 33.03 |
P/FCF Ratio (TTM) | -0.59 | -7.73 |
Price to 5YR AVG Earnings Ratio | -0.06 | -7.08 |
Price to 5YR AVG FCF Ratio | -2.03 | -13.02 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -151.38% | -15.67% |
ROE (TTM) | -289.05% | 27.44% |
Net Profit Margin (TTM) | -153.21% | -627.99% |
ROIC 5YR AVG | 436.03% | -4.84% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -141.64% | 42.96% | -37.51% |
Revenue | -25.00% | -33.33% | -20.00% |
Net Income | -1.94% | 16.40% | -70.72% |
Cash Flow | 14.32% | 9.00% | -148.70% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.10 | 5.66 |
Quick Ratio (TTM) | 3.10 | 5.44 |
D/E Ratio (TTM) | N/A | 1.19 |
Interest Coverage (TTM) | N/A | -5.92 |
Piotroski F-Score | 5 | 5 |
Altman Z-Score | N/A | 13.21 |
LTL to 5YR AVG FCF | N/A | 0.09 |
Shares Outstanding Growth 5YR AVG | 2,587.80% | 39.51% |